Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Intellia Therapeutics, Inc. | d284545dex321.htm |
| EX-31.2 - EX-31.2 - Intellia Therapeutics, Inc. | d284545dex312.htm |
| EX-31.1 - EX-31.1 - Intellia Therapeutics, Inc. | d284545dex311.htm |
| EX-21.1 - EX-21.1 - Intellia Therapeutics, Inc. | d284545dex211.htm |
| 10-K - FORM 10-K - Intellia Therapeutics, Inc. | d284545d10k.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement No. 333-211200 on Form S-8 of our report dated March 14, 2017, relating to the consolidated financial statements of Intellia Therapeutics, Inc. appearing in this Annual Report on Form 10-K of Intellia Therapeutics, Inc. for the year ended December 31, 2016.
| /s/ Deloitte & Touche LLP |
| Boston, Massachusetts |
| March 14, 2017 |